TG Therapeutics | Interessi Passivi Sul Debito



Interest Expense On Debt Cambiamento Data
AbbVie USD 610M 19M 2024-12
Alaunos Therapeutics USD 0 0 2023-12
Amgen USD 747M 29M 2024-12
Ardelyx USD 3.97M 610K 2024-12
Arrowhead Research USD 21.65M 7M 2024-12
Bayer 703M 61M 2024-12
Biogen USD 60M 200K 2024-12
Corcept Therapeutics 6M 6M 2024-06
Dynavax Technologies USD 1.7M 5K 2024-12
Gilead Sciences USD 248M 10M 2024-12
J&J USD 137M 56M 2024-12
Novartis USD 275M 11M 2024-12
PTC Therapeutics USD 42.11M 1.09M 2024-09
Regeneron Pharmaceuticals USD 10.5M 3.3M 2024-12
Roche Holding CHF 311.5M 1000K 2024-12
TG Therapeutics USD 10.83M 6.86M 2024-09
Vertex Pharmaceuticals USD 2.8M 4.7M 2024-12



TG Therapeutics Interessi Passivi Sul Debito - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - Mar 2025.